China announced the revocation of the GeneScience Pharmaceutical license to manufacturer Jintropin brand human growth hormone. This represents a major success in efforts towards the internationalization of steroid and doping law by the United States. The U.S. federal government indicted CEO Lei Jin and GeneScience Pharmaceutical Inc. last fall as part of Operation Raw Deal.
GeneScience (manufacturer of Jintropin HGH) was the only company officially named by Chinese authorities; we suspect the other two Chinese pharmaceutical companies affected were Neogenica Bioscience (manufacturer of Revitropin IGF-1 and Hypertropin HGH) and Kexing (manufacturer of Fitropin HGH) [...]
GeneScience (manufacturer of Jintropin HGH) was the only company officially named by Chinese authorities; we suspect the other two Chinese pharmaceutical companies affected were Neogenica Bioscience (manufacturer of Revitropin IGF-1 and Hypertropin HGH) and Kexing (manufacturer of Fitropin HGH) [...]
China Revokes GeneScience Pharmaceuticals License for Jintropin Human Growth Hormone - MESO-Rx
China announced the revocation of the GeneScience Pharmaceutical license to manufacturer Jintropin brand human growth hormone. This represents a major
thinksteroids.com